Federal grants to Ihp Therapeutics Inc
Ihp Therapeutics Inc in San Carlos, California received $6.4 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Drug Use and Addiction Research Programs, with $3.6 million. In fiscal 2025 it was awarded $982,081.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$6.4 million
- Awards4
- Awarded in FY 2025$982,081
- Largest award$2.6 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 0 | $0 |
| FY 2022 | 1 | $217,928 |
| FY 2023 | 2 | $4.0 million |
| FY 2024 | 1 | $1.2 million |
| FY 2025 | 1 | $982,081 |
Programs that fund Ihp Therapeutics Inc
| Program | Awards | Amount |
|---|---|---|
| Drug Use and Addiction Research Programs | 2 | $3.6 million |
| Cardiovascular Diseases Research | 1 | $2.6 million |
| Military Medical Research and Development | 1 | $217,928 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $6.2 million |
| Department of Defense | 1 | $217,928 |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Development of a novel disease-modifying glycan therapeutic for early at-home intervention of acute vaso-occlusive crisis in sickle cell disease - project summary/abstract current therapies for sickle cell disease largely fail to meet patient needs, particularly for the management of acute pain cris | Cardiovascular Diseases Research | March 5, 2023 | $2.6 million |
| A novel glycan-based selectin and complement inhibitor for at-home disease-modifying rescue of pain crisis in sickle cell disease - sickle cell disease (SCD) is a devastating condition that is widely recognized for its hallmark pain crisis or vaso- occlusive events (VOE). There is currently a lack o | Drug Use and Addiction Research Programs | September 18, 2023 | $2.6 million |
| A novel glycan-based selectin and complement inhibitor for at-home disease-modifying rescue of pain crisis in sickle cell disease - sickle cell disease (SCD) is a devastating condition that is widely recognized for its hallmark pain crisis or vaso- occlusive events (VOE). There is currently a lack o | Drug Use and Addiction Research Programs | August 29, 2025 | $982,081 |
| Novel glycan therapeutic to treat ards | Military Medical Research and Development | March 3, 2022 | $217,928 |
Questions people ask
How much federal grant money does Ihp Therapeutics Inc get?
$6.4 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Ihp Therapeutics Inc the most?
The Department of Health and Human Services, with $6.2 million in 3 awards. The Department of Defense follow.
What is Ihp Therapeutics Inc's largest federal grant?
$2.6 million under Cardiovascular Diseases Research, with its first action in the period on March 5, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Ihp Therapeutics Inc?
Its largest are Drug Use and Addiction Research Programs, Cardiovascular Diseases Research and Military Medical Research and Development.
Other grant recipients in San Carlos
- Peninsula Corridor Joint Powers Board
- San Mateo County Transit District
- Swift Solar Inc
- Village Enterprise Fund, Inc.
- Dorian Therapeutics Inc
- Siolta Therapeutics Inc
- Onc.ai, Inc.
- Envivo Bio Inc
Largest federal grant recipients in California · Federal grants in California